EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Icariside II attenuates isoproterenol-induced myocardial ischemia by regulating NLRP3/Caspase-1 axis

Wenzhong Feng, Dongfei Fang, Fangying Tang, Jianmei Gao, Fuchao Chen, Zhihao Li, Cancan Duan, Yan Zhang, Ming Yu, Pingping Wang, Jianyong Zhang

Science of Traditional Chinese Medicine · 2025-03 · 3 (1) · 40-51

DOI: 10.1097/st9.0000000000000057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science of Traditional Chinese Medicine, online erschienen am 24.01.2025. Verfasst von Wenzhong Feng und 10 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epimedii Folium, first recorded in the Shennong’s Classic of Materia Medica ( Shen Nong Ben Cao Jing ), is a traditional Chinese medicine (TCM) known for its effects of “benefiting Qi and strengthening the heart.” Icariside II (ICS II) is one of the main active components of Epimedii Folium, possessing cardiovascular protective and anti-inflammatory properties. However, the potential mechanisms of ICS II on myocardial ischemia (MI) remain unclear.

Objective

The aim of the study was to investigate the effects and preliminary molecular mechanisms of ICS II in treating isoproterenol-induced MI in rats.

Methods

A rat model of MI was established by subcutaneous injection of isoproterenol. Electrocardiography, echocardiography, myocardial enzymes analysis, heart weight index, triphenyltetrazolium chloride staining, histopathology, TUNEL staining, RT-qPCR, and Western blot were employed to evaluate the effects and preliminary molecular mechanisms of ICS II on MI rats.

Results

Pharmacodynamic studies suggested that ICS II inhibited ST-segment elevation in electrocardiograms, improved cardiac function, reduced heart weight index and myocardial enzyme levels, decreased myocardial infarct size, alleviated cardiac histological damage, and inhibited apoptosis, thereby exerting cardioprotective effects in MI rats. Further studies revealed that ICS II may partially inhibit the expression of NLRP3/Caspase-1 axis-related targets at both protein and mRNA levels.

Conclusions

Our findings indicate that ICS II exerts anti-MI effects, and its preliminary molecular mechanisms may be related to inhibiting the activation of the NLRP3/Caspase-1 axis to alleviate inflammatory responses.

Zitieren

APA

Feng, W., Fang, D., Tang, F., Gao, J., Chen, F., Li, Z., Duan, C., Zhang, Y., Yu, M., Wang, P., & Zhang, J. (2025). Icariside II attenuates isoproterenol-induced myocardial ischemia by regulating NLRP3/Caspase-1 axis. Science of Traditional Chinese Medicine, 3(1), 40-51. https://doi.org/10.1097/st9.0000000000000057

Vancouver

Feng W, Fang D, Tang F, Gao J, Chen F, Li Z, et al. Icariside II attenuates isoproterenol-induced myocardial ischemia by regulating NLRP3/Caspase-1 axis. Science of Traditional Chinese Medicine. 2025;3(1):40-51. doi:10.1097/st9.0000000000000057

BibTeX
@article{Feng2025,
  author = {Feng, Wenzhong and Fang, Dongfei and Tang, Fangying and Gao, Jianmei and Chen, Fuchao and Li, Zhihao and Duan, Cancan and Zhang, Yan and Yu, Ming and Wang, Pingping and Zhang, Jianyong},
  title = {Icariside II attenuates isoproterenol-induced myocardial ischemia by regulating NLRP3/Caspase-1 axis},
  journal = {Science of Traditional Chinese Medicine},
  year = {2025},
  volume = {3},
  number = {1},
  pages = {40--51},
  doi = {10.1097/st9.0000000000000057}
}
Kostenlos starten →